Skip to content
Online Prescribing
  • Home
  • Services
    • Consultancy
    • Subscribe
    • Guarantee
  • Shop
  • Blog
  • About Us
  • Contact Us
    • Survey

antidepressant

  • Home
  • Blog
  • antidepressant

Frequently Asked Questions about Esketamine

Posted by By Mike Bereza August 18, 2020Posted inDigital Health1 Comment
"I have Bi Polar Type 2 (not officially diagnosed as my GP had already started my treatment on mood stabiliser Olanzapine) I am diagnosed as having Major depression, I’m on…
Read More

Esketamine as an Antidepressant

Posted by By Mike Bereza May 22, 2019Posted inDigital Health, New Medicines, Psychedelic-Assisted Psychotherapy, PsychedelicsNo Comments
Major depressive disorder (MDD) is a significant cause of disability worldwide and the most common illness preceding suicide. On March 5, 2019, the nasal spray drug, esketamine, also known as Spravato (by Janssen…
Read More

Recent Posts

  • How Ibogaine Differs from Other Psychedelic Therapies: A Clinical Comparison
  • Australian Online Prescribing Requirements
  • US Online Prescribing Requirements
  • UK Online Prescribing Requirements
  • List of Controlled Drugs on Ships

Recent Comments

  1. Mike Bereza on Ibogaine Treatment in Australia: A Revolutionary Approach to Addiction Therapy
  2. Teresa on Ibogaine Treatment in Australia: A Revolutionary Approach to Addiction Therapy
  3. Mike Bereza on Ibogaine Treatment in Australia: A Revolutionary Approach to Addiction Therapy
  4. Janine on Ibogaine Treatment in Australia: A Revolutionary Approach to Addiction Therapy
  5. Mike Bereza on Ibogaine Treatment in Australia: A Revolutionary Approach to Addiction Therapy
Copyright 2025 — Online Prescribing. All rights reserved.
Scroll to Top